文献速递药物不良反应与药物警戒特殊人群用药治疗药物监测与药物基因组学

德国莱茵兰研究:多重用药、潜在不适当用药与药物基因组学风险

Polypharmacy, potentially inappropriate medication and pharmacogenomics drug exposure in the Rhineland Study.
PubMed 文献 · Br J Clin Pharmacol · 2021-02-05

该研究基于德国波恩莱茵兰研究队列前5000名≥30岁参与者的横断面访谈数据,评估常规用药及三种药物不良反应风险因素。结果显示66.0%参与者常规用药,≥65岁者达87.4%;多重用药、潜在不适当用药和药物基因组学药物暴露率分别为15.9%、6.4%和20.5%。≥65岁者中54.1%至少有一种风险因素,27.4%至少有两种。

要点

  • ≥65岁参与者中87.4%常规用药,多重用药率15.9%、潜在不适当用药率6.4%。
  • ≥65岁者54.1%至少有一种药物不良反应风险因素,27.4%至少有两种。
  • 药物基因组学药物暴露率20.5%,提示需关注基因多态性对药物代谢的影响。

核心结论

  • 研究人群中药物使用普遍,个体发生药物不良反应的风险较高,提示一般用药存在改善空间。

研究设计与样本

  • 基于德国波恩莱茵兰研究队列的横断面访谈式药物数据收集,纳入前5000名≥30岁参与者,平均年龄55岁,57%为女性。

主要发现

  • 66.0%的参与者报告定期使用药物,≥65岁参与者(n=1301)中该比例升至87.4%。
  • 多重用药、潜在不适当用药和药物基因组学药物暴露率分别为15.9%、6.4%和20.5%。
  • <65岁参与者中16.0%(95%CI 14.8,17.3)至少有一种风险因素。
  • ≥65岁参与者中54.1%(95%CI 51.4,56.8)至少有一种风险因素,27.4%(95%CI 25.0,29.9)至少有两种风险因素。

临床怎么用

  • 临床药师应关注老年患者多重用药和潜在不适当用药的筛查,并结合药物基因组学信息评估药物代谢相关风险。

局限性

  • 研究为横断面设计,无法推断因果关系;药物数据基于访谈自我报告,可能存在回忆偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: High medication use may contribute to the efficiency of drug therapy in general, but it could also increase the burden of adverse drug reactions. We aimed to assess medication use and the prevalence of three risk factors for adverse drug reactions: the use of polypharmacy, potentially inappropriate medication in the elderly and pharmacogenomic polymorphisms affecting the metabolism of drugs. METHODS: Cross-sectional interview-based medication data (including over-the-counter drugs) was collected in a large population-based cohort (≥30 years of age) in Bonn, Germany. RESULTS: Analyses were based on the first 5000 participants of the Rhineland Study (mean age 55 years, 57% women). Of our participants, 66.0% reported the use of a drug regularly, which increased to 87.4% in participants aged ≥65 years (n = 1301). The rates of use of polypharmacy, potentially inappropriate medication and pharmacogenomic drugs were 15.9%, 6.4% and 20.5%, respectively. In participants <65 years, 16.0% (95% CI 14.8, 17.3) had at least one risk factor. In participants aged ≥65 years, 54.1% (95% CI 51.4, 56.8) had at least one and 27.4% (95% CI 25.0, 29.9) had at least two risk factors. Extrapolating these numbers to the German population implies that around 9 million of the 17 million individuals aged 65 years or older are potentially at an elevated risk for adverse drug reactions, of which 4.6 million are at a potentially highly elevated risk for adverse drug reactions. CONCLUSION: Our study shows that drug use is common and the individual risk for an adverse drug reaction in our population is high. This suggests room for improvement in general medication use.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. de Vries FM, Stingl JC, Breteler MMB, et al. Polypharmacy, potentially inappropriate medication and pharmacogenomics drug exposure in the Rhineland Study. Br J Clin Pharmacol. 2021. PMID: 33232531. doi:10.1111/bcp.14671

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。